JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Anaesthesia Section DOI : 10.7860/JCDR/2015/14964.6457
Year : 2015 | Month : Sep | Volume : 9 | Issue : 9 Full Version Page : UC14 - UC18

Evaluation of Efficacy of Epidural Clonidine with 0.5% Bupivacaine for Postoperative Analgesia for Orthopaedic Lower Limb Surgeries

Karthik Krishnamoorthy1, Saravanan Ravi2, Ilango Ganesan2

1 Assistant Professor, Department of Anaesthesiology, SRM Medical College Hospital and Research Centre, Potheri, India.
2 Assistant Professor, Department of Anaesthesiology, SRM Medical College Hospital and Research Centre, Potheri, India.
3 Associate Professor, Department of Anaesthesiology, ESI Post Graduate Institute of Medical Science and Research, Chennai, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Karthik Krishnamoorthy, Plot No-8, Meadow Villas Phase-2, Cto Colony 3rd St Ext, West Tambaram, Chennai, Tamilnadu-600045, India. E-mail : Karthikkrishnamoorthy1981@gmail.com
Abstract

Objective

The objective of this study is to evaluate the efficacy of epidural clonidine in intra and postoperative analgesia, the level of sedation caused by clonidine and monitor its side effects.

Materials and Methods

Forty patients of ASA1 & ASA2 scheduled for lower limb orthopaediac surgeries were chosen for the study. Study group received 50μg of clonidine diluted to 1ml along with first dose of epidural injection and Control group received 1ml of normal saline along with first dose of epidural. Intra and postoperative vitals, verbal pain rating scale (VRS), sedation score and number of rescue anlgesics required postoperatively were noted. Patients received rescue analgesic when VRS was 1.

Results

Addition of clonidine to bupivacaine definitely improves the quality of analgesia by reducing the overall pain score, prolonging the duration of the time of first rescue analgesia and causing reduction of total analgesic consumption in the postoperative period without any hemodynamic instability. Sedation may be beneficial during the intraoperative period.

Conclusion

Epidural clonidine produces long lasting, good quality analgesia with good level of sedation and with minimal side effects.

Keywords

Introduction

Recent advances in neurosciences have demonstrated that peripheral tissue injury may lead to long alterations in central processing with reduction in pain threshold, amplification of response to pain. Comparable alterations may also occur following surgical trauma, resulting in amplification and prolongation of postoperative pain.

Postoperative pain may give rise to various physiological and psychological phenomena and hence postoperative pain treatment should be an integral component of the routine surgical and anaesthetic management because it can help to reduce morbidity and complications as well as accelerate rehabilitation [1]. Good and effective perioperative pain control attenuates the surgical stress response and is vital for early mobilization and postoperative discharge [2].

Regional anaesthesia is the most frequently used anaesthesia for orthopaedic lower limb surgeries. Epidural anaesthesia is a central neuraxial block technique with many applications. Epidural anaesthesia can be used as sole anaesthetic for procedures involving the lower limbs, pelvis and lower abdomen. The main advantage of epidural anaesthesia is the ability to maintain continuous anaesthesia after placement of an epidural catheter, thus making it suitable for procedures of longer duration. This feature of retaining the epidural catheter also enables the use of this technique into the postoperative period for analgesia, using lower concentrations of local anaesthetic drugs or in combination with different agents.

Clonidine hydrochloride is an imidazole derivative with alpha–2 adrenergic agonistic activity, can be used as an additive to local anaesthetics in nerve blockade and central neuraxial blockade. Following local anaesthetics and opioids, clonidine is the most studied drug used for human neuraxial analgesia. Although the systemic administration of clonidine can provide analgesia, its primary site of antinociceptive action appears to be at the spinal level [3]. Alpha - 2 receptors at the spinal cord level are thought to be responsible for the analgesic properties of α2-adrenergic agonists.

This study was designed to evaluate the analgesic efficacy of bupivacaine and clonidine mixture given through lumbar epidural route in patients undergoing elective orthopaedic lower limb surgeries, comparing the quality of analgesia with epidural pain bupivacaine and also to calculate the number of postoperative analgesic doses required.

Materials and Methods

This randomized and placebo controlled study was performed at a Tertiary Medical College Hospital in Chennai. Forty patients were chosen for the study and by simple random sampling they were divided as 20 patients for each group. Patients who were posted for orthopaedic lower limb surgeries in the age group of 18 years to 65 years belonging to ASA physical status I & II were chosen for the study. After getting approval by the institutional ethical committee and after obtaining written informed consent from each patient, the study was conducted.

All patients were assessed preoperatively before enrolling for the study. No premedication was given. On arrival in the operating room, baseline cardio respiratory parameters viz., Heart Rate (HR), Systolic blood pressure (SBP), Diastolic blood pressure (DBP), Mean arterial pressure (MAP) and Respiratory rate (RR) were recorded. A good intravenous access was established using 18G IV cannula. Preloading was done with ringer’s lactate solution at 10 ml/kg.

Patients were allocated randomly into two equal groups (20 in each group). Group P (placebo) received 1 ml of normal saline with the first dose of epidural 0.5% bupivacaine. Group C (clonidine) received 50μg of fixed dose of clonidine diluted with normal saline to 1 ml epidurally along with the first dose of bupivacaine.

With the patient in sitting posture, after informing the procedure to the patient & under strict aseptic precautions, epidural space was identified at L3-L4 interspace using 16G Tuohy needle by loss of resistance technique. Epidural catheter was threaded in a cephalad direction & 4 cm of catheter length was kept inside the epidural space. A test dose of 3 cc of 1.5 % lignocaine with adrenaline (5μg/ml) was given. After confirming negative result for test dose, epidural catheter was fixed and secured with tapes. A standard anaesthetic technique was followed in all patients.

Epidural 1st dose - 14 ml of 0.5% bupivacaine + 1ml of placebo or 50 μg of injection clonidine diluted with normal saline to 1 ml.

Epidural 2nd dose - 6ml of 0.5% bupivacaine (90 min after 1st dose)

Patients with duration of surgery between 2-2:30 hours requiring standard 2 doses of epidural local anaesthetics were only taken up for study. Time of incision was noted. Heart rate (HR), Systolic blood pressure (SBP), Diastolic blood pressure (DBP), Mean arterial pressure (MAP) and Respiratory rate (RR) were continuously monitored intraoperatively and noted every 10 min. Ramsay sedation scale (RSS) was also noted every 30 min.

All patients were given oxygen supplementation (4-5 L/min) through Hudson’s face mask. No intravenous opioid analgesics were supplemented during the study. Intravenous fluid management was done based on Mean arterial blood pressure and surgical blood loss.

Ramsay Sedation Scale

Patient is anxious and agitated or restless, or both.

Patient is co-operative, oriented and tranquil.

Patient responds to commands only.

Patient exhibits brisk response to light glabellar tap or loud auditory stimulus.

Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus.

Patient exhibits no response.

The epidural catheter was retained in position. Postoperatively the patient was transferred to the Post Anaesthetic Care Unit (PACU) where PR, SBP, DBP, SPO2 & RR monitored continuously and recorded every hour. The intensity of pain was measured by using the verbal pain rating scale.

Pain Score (Verbal Rating Score)

Grade 0 - No complaint of pain

Grade 1 - Patient complaints of pain but tolerable (mild pain)

Grade 2 - Patient complaining of severe pain and demands relief (Moderate pain)

Grade 3 - Patient restless and screaming with pain (Severe pain)

When the patient complained of pain, the pain intensity was assessed based on verbal rating scale & if pain score reaches 1, epidural top up of 6ml of 0.125% bupivacaine was given to the patient.

The time of first rescue analgesia (TFA) was calculated from the time of injection of study drug in the epidural space to the time when the verbal rating pain score reached 1 in the postoperative period. Number of epidural top-ups (6 ml of 0.125% bupivacaine) required by each patient for a period of 48 hours was noted in both the groups. Patients were observed for any side effects like hypotension, bradycardia, respiratory, depression and shivering.

Results

Patients in both the groups were similar in terms of age, sex, height, weight distribution [Table/Fig-1] and type of surgery. All the data were expressed as mean ± standard deviation (SD). Qualitative variables were compared with ‘Chi-square test’ and quantitative variables were compared with the ‘student t-test’. The level of statistical significance was set at p < 0.05. There was no significant difference in the duration of surgery (hour) between the two groups [Table/Fig-2].

Comparison of age, sex, height and weight distribution

S.NOPARAMETERSGROUPp-VALUE
GROUP PGROUP C
MEAN ± SDMEAN ± SD
1.Age (y)40.60 ± 7.4036.85 ± 9.59p-0.183(NOT SIGNIFICANT)
2.Gender (Male:Female)15:517:3p-0.695(NOT SIGNIFICANT)
3.Height (cm)164.00±5.73166.65±6.01p-0.152(Not Significant)
4.Weight (kg)59.60±5.1659.50±6.10p-0.956(Not Significant)

Duration of surgery

GROUP PGROUP Cp-VALUE
DURATION OF SURGERY(h)2.14 ± 0.072.12 ± 0.07p – 0.359NOT SIGNIFICANT

During the intraoperative monitoring, there were no significant changes in heart rate [Table/Fig-3] and respiratory rate [Table/Fig-4] among the two groups. Difference in Systolic blood pressure monitoring between two groups were found to be significant only during 60,70,110,120,130,150 minutes [Table/Fig-5]. Difference in Intraoperative Diastolic Blood Pressure monitoring between the two groups were found to be significant only during 60, 70 and 110 minutes [Table/Fig-6]. Difference in Intraoperative Mean Arterial Pressure monitoring between the two groups were found to be significant only during 60, 70 and 110 minutes [Table/Fig-7].

Heart rate

S.NOPARAMETERS(MIN)GROUPP-VALUEP<0.05-SIG
GROUP PGROUP C
MEAN ± SDMEAN ± SD
1.HR PRE-OP94.10 ± 11.8197.05 ± 12.81.441(NOT SIG)
2.HR1092.20 ± 8.1694.70 ± 11.69.438(NOT SIG)
3.HR2088.90 ± 8.7090.40 ± 12.12.656(NOT SIG)
4.HR3085.95 ± 7.5287.30 ± 11.77.668(NOT SIG)
5.HR4084.80 ± 8.2987.10 ± 12.81.504(NOT SIG)
6.HR5083.85 ± 8.3485.45 ± 13.03.646(NOT SIG)
7.HR6082.75 ± 8.6684.90 ± 11.79.515(NOT SIG)
8.HR7081.95 ± 9.2482.55 ± 10.73.851(NOT SIG)
9.HR8082.35 ± 8.9681.65 ± 9.9.52.812(NOT SIG)
10.HR9083.00 ± 9.5982.00 ± 11.94.908(NOT SIG)
11.HR10084.55 ± 9.0283.6 ± 10.51.761(NOT SIG)
12.HR11086.30 ± 7.5585.7 ± 10.26.834(NOT SIG)
13.HR12084.15 ± 10.0086.85 ± 10.21.594(NOT SIG)
14.HR13087.30 ± 8.4186.20 ± 10.28.713(NOT SIG)
15.HR14087.00 ± 8.6088.65 ± 11.08.602(NOT SIG)
16.HR15090.70 ± 8.9890.70 ± 10.531.00(NOT SIG)

Respiratory rate

S.NOPARAMETERS(MIN)GROUPP-VALUEP<0.05-SIG
GROUP PGROUP C
MEAN ± SDMEAN ± SD
1.RR PRE OP15.80 ± 1.5819.75 ± 1.560.268(NOT SIG)
2.RR 1014.45 ± 1.4715.20 ± 1.280.093(NOT SIG)
3.RR 2014.65 ± 1.8715.10 ± 1.410.396(NOT SIG)
4.RR 3014.40 ± 2.3714.55 ± 1.760.822(NOT SIG)
5.RR 4014.10 ± 2.0414.30 ± 1.450.724(NOT SIG)
6.RR 5014.25 ± 1.5814.30 ± 1.490.919(NOT SIG)
7.RR 6014.45 ± 2.0114.45±1.271.000(NOT SIG)
8.RR 7014.55 ± 2.4414.65 ± 1.270.872(NOT SIG)
9.RR 8014.70 ± 2.1214.85 ± 1.350.792(NOT SIG)
10RR 9014.50 ± 1.7614.35 ± 1.560.777(NOT SIG)
11.RR 10014.60 ± 1.5014.35 ± 1.350.583(NOT SIG)
12.RR 11014.80 ± 1.7314.40 ± 1.530.445(NOT SIG)
13.RR 12014.75 ± 2.0714.80 ± 1.050.923(NOT SIG)
14.RR 13015.50 ± 2.9115.00 ± 1.170.480(NOT SIG)
15.RR 14014.95± 1.4714.90 ± 0.970.899(NOT SIG)
16.RR 15015.00 ± 1.4515.05 ± 0.990.900(NOT SIG)

Systolic blood pressure

S.NOPARAMETERS(MIN)GROUPp-VALUEp<0.05-SIG
GROUP PGROUP C
MEAN ± SDMEAN ± SD
1.SBP PRE-OP128.80 ± 6.68130.20 ± 6.470.505(NOT SIG)
2.SBP 10120.20 ± 11.70118.65 ± 5.850.600(NOT SIG)
3.SBP 20110.05 ± 11.64107.40 ± 10.880.462(NOT SIG)
4.SBP 30113.85 ± 13.51112.70 ± 6.850.736(NOT SIG)
5.SBP 40114.90 ± 9.29108.30 ± 22.370.231(NOT SIG)
6.SBP 50116.00 ± 8.57111.05 ± 7.160.055(NOT SIG)
7.SBP 60115.70 ± 9.81110.25 ± 5.980.041(SIG)
8.SBP 70116.00 ± 7.38108.70 ± 8.970.008(SIG)
9.SBP 80114.80 ± 7.96112.95 ± 7.510.454(NOT SIG)
10.SBP 90114.50 ± 7.04111.80 ± 8.470.280(NOT SIG)
11.SBP 100113.65 ± 8.56110.35 ± 7.880.212(NOT SIG)
12.SBP 110118.35 ± 5.38112.45 ± 7.300.006(SIG)
13.SBP 120120.35 ± 5.33113.75 ± 8.900.007(SIG)
14.SBP 130117.55 ± 5.05113.00 ± 8.370.044(SIG)
15.SBP 140118.70 ± 6.34114.80 ± 7.460.083(NOT SIG)
16.SBP 150124.10 ± 3.74120.00 ± 8.030.045(SIG)

Diastolic blood pressure

S.NOPARAMETERS(MIN)GROUPP-VALUEP<0.05-SIG
GROUP PGROUP C
MEAN ± SDMEAN ± SD
1.DBP PRE OP82.40 ± 3.0181.85 ± 4.930.673(NOT SIG)
2.DBP 1075.20 ± 8.7074.00± 6.020.615(NOT SIG)
3.DBP 2068.15± 10.3865.50 ± 10.180.420(NOT SIG)
4.DBP 3069.40 ± 9.6369.15 ± 6.360.923(NOT SIG)
5.DBP 4071.60 ± 7.8067.65 ± 15.140.306(NOT SIG)
6.DBP 5072.20 ± 8.3568.70 ± 4.470.107(NOT SIG)
7.DBP 6073.20 ± 7.8867.85 ± 3.740.009(SIG)
8.DBP 7072.55 ± 7.7566.95 ± 5.600.013(SIG)
9.DBP 8071.75 ± 6.4870.70± 4.950.568(NOT SIG)
10DBP 9072.65 ± 6.5569.45 ± 4.870.088(NOT SIG)
11.DBP 10072.50 ± 7.4969.85 ± 5.540.211(NOT SIG)
12.DBP 11074.30 ± 5.1070.45 ± 4.420.015(SIG)
13.DBP 12075.35 ± 6.6771.85 ± 5.610.080(NOT SIG)
14.DBP 13073.30 ± 5.1970.95 ± 5.070.156(NOT SIG)
15.DBP 14074.90 ± 6.2071.65 ± 4.330.062(NOT SIG)
16.DBP 15079.15 ± 3.0478.10 ± 4.610.401(NOT SIG)

Mean arterial pressure

S.NOPARAMETERS(MIN)GROUPP-VALUEP<0.05-SIG
GROUP PGROUP C
MEAN ± SDMEAN ± SD
1.MAP PRE OP97.85 ± 3.5197.90 ± 4.740.970(NOT SIG)
2.MAP 1090.40 ± 9.3488.80 ± 5.610.516(NOT SIG)
3.MAP 2081.85 ± 10.0578.85 ± 10.350.359(NOT SIG)
4.MAP 3083.85 ± 9.9483.80 ± 5.520.984(NOT SIG)
5.MAP 4086.20 ± 8.1584.65 ± 4.580.463(NOT SIG)
6.MAP 5086.70 ± 8.1583.00 ± 4.660.086(NOT SIG)
7.MAP 6088.25 ± 8.9782.05 ± 4.310.008(SIG)
8.MAP 7086.90 ± 7.3880.85 ± 6.440.009(SIG)
9.MAP 8086.00 ± 6.5884.70 ± 5.550.504(NOT SIG)
10.MAP 9086.40 ± 6.3283.45± 5.770.132(NOT SIG)
11.MAP 10085.85 ± 7.7683.65± 5.310.302(NOT SIG)
12.MAP 11089.35 ± 5.3084.60 ± 5.040.006(SIG)
13.MAP 12089.80 ± 6.1385.85 ± 6.220.050(NOT SIG)
14.MAP 13088.25 ± 4.3585.05 ± 5.790.055(NOT SIG)
15.MAP 14088.90 ± 6.0786.20 ± 4.800.127(NOT SIG)
16.MAP 15094.00 ± 2.9591.75 ± 5.150.098(NOT SIG)

According to Chi- square test, Difference in Ramsay Sedation Scale (RSS) between the two groups was significant at 30 min (p-0.003), 60 min (p<0.001) and 90 min (P<0.001). Difference in RSS between the two groups was not significant at 120 min and 150 min respectively [Table/Fig-8].

Ramsay sedation scale

TIME (min)RSSGROUP PGROUP CTOTALP-VALUE
301 Count% Within Group20100%1260%3280%0.003
2 Count% Within Group00%840%820%
601 Count% Within Group20100%00%2050%<0.001
2 Count% Within Group00%20100%2050%
901 Count% Within Group20100%630%2665%<0.001
2 Count% Within Group00%1470%1435%
1201 Count% Within Group20100%1995%3997.5%0.999
2 Count% Within Group00%15%12.5
1501 Count% Within Group20100%20100%40100%1.000

The postoperative pain score (verbal rating scale) was found to be significantly low at 4, 12, 18 and 24 hours in Group C when compared to Group P. Significantly low pain scores were observed at 4, 12, 18 and 24 hours intervals in patients belonging to Group C (p < 0.001 at 4,12 and 24 hours intervals and p -0.004 at 18 hours interval) than Group P [Table/Fig-9]. The study demonstrated that pain relief was significantly better (p < 0.05) in patients who received epidural bupivacaine with clonidine than the patients who received epidural bupivacaine with placebo. The mean time of first rescue analgesia (hours) was found to be (6.05±0.65 hours) in Group C as compared to (3.27±0.53 hours) observed in Group P which was statistically significant (P-0.001) [Table/Fig-10].

Verbal rating scale

TIME IN HOURSRSSGROUP PGROUP CTOTALCHI-SQUARE TEST
20 COUNT%WITH IN GROUP1890%20100%3895%p-0.487NOT SIG
2 COUNT% WITH IN GROUP210%00%25%
40 COUNT% WITH IN GROUP00%1995%1947.5p<0.001SIG
1 COUNT% WITH IN GROUP1680%15%1742
2 COUNT% WITH IN GROUP4100%0100%4100%
60 COUNT% WITH IN GROUP630%840%1435%p-0.741NOT SIG
1 COUNT% WITH IN GROUP1470%1260%2665%
80 COUNT% WITH IN GROUP00%420%410%p-0.072NOT SIG
1 COUNT% WITH IN GROUP1995%1685%3587.5%
2 COUNT% WITH IN GROUP15%00%12.5%
120 COUNT% WITH IN GROUP00%210%250%p<0.001SIG
1 COUNT% WITH IN GROUP735%1890%2562.5%
2 COUNT% WITH IN GROUP1365%00%1332.5%
181 COUNT% WITH IN GROUP525%1575%2050%p-0.004SIG
2 COUNT% WITH IN GROUP1575%525%2050%
241 COUNT% WITH IN GROUP15%1155%1230%p-0.001SIG
2 COUNT% WITH IN GROUP1995%945%2870%
361 COUNT% WITH IN GROUP1890%20100%3895%p-0.487NOT SIG
2 COUNT% WITH IN GROUP290%00%25%
481 COUNT% WITH IN GROUP00%210%25%p-0.487NOT SIG
2 COUNT% WITH IN GROUP20100%20100%40100%

Time of first rescue analgesia

GROUPP-VALUE
GROUP PGROUP C
Time of first rescue analgesia (h)3.27 ±0.536.05 ± 0.650.001SIGNIFICANT

The no of postoperative epidural top ups for next 48 hours were significantly low (4 or 5 doses) in group C compared to (6 or 7 doses) in Group P [Table/Fig-11].

No of epidural top ups

NO. OF DOSESGROUPTotal
GROUP PGROUP C
4Count01919
% within GROUP0%95.0%47.5%
5Count011
% within GROUP0%5.0%2.5%
6Count15015
% within GROUP75.0%0%37.5%
7Count505
% within GROUP25.0%0%12.5%
TotalCount202040
% within GROUP100.0%100.0%100.0%

Discussion

A number of clinical trials have been conducted to prove the efficacy of anti- nociceptive effect of α2 agonists using different techniques and different types of drugs with conflicting results. The use of epidural techniques also offers the advantage of effective prolonged postoperative analgesia as compared to nerve blocks and local infiltrations.

The dose-dependent antinociceptive effects of clonidine were demonstrated in 1981. These effects are partly mediated by spinal cord muscarinic and nicotinic receptors and the release of acetylcholine and by the activation of inhibitory noradrenergic pathways. In experimental studies, animal models and clinical trials, subarachnoid opioids, local anaesthetics and α2 adrenergic agonists show synergistic or additive interactions. Intrathecal or epidural clonidine is not neurotoxic [3].

In this randomized and placebo controlled study, we have evaluated the analgesic efficacy of bupivacaine with clonidine mixture given through lumbar epidural route in patients undergoing orthopaedic lower limb surgeries.

In this study, we found that bupivacaine and clonidine administered epidurally, reduced the amount of analgesic that patients required postoperatively suggesting that clonidine may enhance the analgesic effect of bupivacaine. This study correlates with the meta-analysis done by Armand et al., which concluded that epidural clonidine clearly produced an analgesic effect and reduced the need for other analgesics [4].

The level of sedation intraoperatively was monitored using Ramsay Sedation Scale. The patients in Group C were well sedated and comfortable than in Group P [Table/Fig-8]. This study correlates with the study conducted by Vieira AM et al., and Parker RK et al., in which they concluded that the association of clonidine and local anaesthetic (ropivacaine [5,6], bupivacaine [79]) had produced longer analgesia and sedation [10].

Pain intensity was assessed using the verbal rating scale (VRS) postoperatively. Significant lower VRS scores after 2,4,6,8,12,18,24,36,48 hours [Table/Fig-9], in group C has demonstrated the clinical advantage of administering mixture of bupivacaine and clonidine through lumbar epidural route for effective postoperative analgesia [8,1117].

Duration of analgesia was significantly more in group C patients receiving bupivacaine and clonidine mixture (6.05±0.64 h) as compared to Group P (3.26±0.53 h). The demand for supplementary epidural top-ups over 48 hours postoperatively was significantly low in group C than Group P [Table/Fig-10]. This correlates with the study of Armand et al., [4].

In this study the dosage of clonidine was fixed at 50 μg for all patients in Group C. Because of the low dose of clonidine used, when compared to Thimmappa M et al., and Gupta S et al., the incidence of side effects were very low [6,8]. Two patients of placebo Group (10% of Group P) and two patients of clonidine group (10% of Group C) had episodes of hypotension with a MAP< 70 mm Hg during intraoperative period [Table/Fig-4,5 and 6] who were managed with a single dose of ephedrine 6 mg iv and crystalloids, and this may be as a result of epidural bupivacaine as such. Postoperatively none of the patients had episode of hypotension. No incidence of any bradycardia [Table/Fig-3] was noted in both the group during intraoperative and postoperative period.

Conclusion

Single dose administration of clonidine and bupivacaine mixture given through lumbar epidural route provides effective postoperative analgesia in patients undergoing elective orthopaedic lower limb surgeries, without any hemodynamic instability. Epidural clonidine significantly reduces the postoperative analgesic consumption and also provides good sedation.

References

[1]Rodgers A, Walker N, Schug S, Reduction of post operative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials BMJ 2000 321:1493-97.  [Google Scholar]

[2]Vekatraman R, Sandhiya R, Evaluation of Efficacy of Epidural Butorphanol Tartarate for Postoperative Analgesia International J of Pharmacy and Pharmaceutical Sciences 2015 7(2):52-54.  [Google Scholar]

[3]Asano T, Dohi S, Ohta S, Shimonaka H, Iida H, Antinociception by epidural and systemic alpha (2)-adrenoceptor agonists and their binding affinity in rat spinal cord and brain Anesth Analg 2000 90:400-07.  [Google Scholar]

[4]Armand S, Langlade A, Boutros A, Lobjoit K, Monrigal C, Ramboatiana R, Meta-analysis of the efficacy of extradural clonidine to relieve postoperative pain: An impossible task Br J Anaesth 1998 81:126-34.  [Google Scholar]

[5]Vieira AM, Schnaider TB, Costa FA, Analgesia and sedation with epidural clonidine associated to 0.75% ropivacaine in the postoperative period of open cholecystectomy Rev Bras Anestesiol. [online] 2003 53(5):586-90.  [Google Scholar]

[6]Thimmappa M, Madhusudhanan R, Potli S, A Comparative study of Epidural Ropivacaine 0.75% alone with Ropivacaine plus Clonidine and Ropivacaine plus Dexmedetomidine for lower abdominal and lower limb surgeries World Journal of Pharmacy and Pharmaceutical Sciences 2014 3(4):1218-30.  [Google Scholar]

[7]Parker RK, Connelly NR, Lucas T, Epidural clonidine added to a bupivacaine infusion increases analgesic duration in labor without adverse maternal or fetal effects J Anaesth 2007 21(2):142-47.  [Google Scholar]

[8]Gupta S, Raval D, Patel M, Patel N, Shah N, Addition of epidural Clonidine enhances postoperative analgesia: A double-blind study in total knee- replacement surgeries Anesth Essays Res 2010 4:70-74.  [Google Scholar]

[9]Karnawat R, Chhabra S, Mohammed S, Comparison of effect of epidural bupivacaine, epidural bupivacaine plus fentanyl and epidural bupivacaine pus clonidine on postoperative analgesia after Hip surgery J Anaesth Clin Res 2013 4:37  [Google Scholar]

[10]Hall JE, Uhrich TD, Ebert TJ, Sedative, analgesic and cognitive effects of clonidine infusions in humans Br J Anaesth 2001 86:5-11.  [Google Scholar]

[11]Choudhary A, Siddiqui S A, Sharma R, Comparative study of analgesic effect of Epidural Clonidine and Magnesium sulfate as an Adjuvant to Bupivacaine in Orthopaedic Lower Limb surgeries Global J for Research Analysis 2014 9(2):96-98.  [Google Scholar]

[12]Vieira AM, Schnaider TB, Brandño ACA, Epidural clonidine or dexmedetomidine for post-cholecystectomy analgesia and sedation Rev Bra Anestesiol 2004 54(4):473-78.  [Google Scholar]

[13]Jain J, Joad AK, Jain V, Epidural clonidine for postoperative pain after lower abdominal surgery: A dose - response study Indian J Pain 2013 27:67-74.  [Google Scholar]

[14]Niyogi S, Santra S, Chakraborty J, A comparative study of duration of postoperative analgesia between epidural bupivacaine and epidural clonidine plus bupivacaine in lumbar laminectomy surgery under general anaesthesia J Indian Medical Association 2011 109(4):230-33.  [Google Scholar]

[15]Huang YS, Lin LC, Huh BK, Sheen MJ, Yeh CC, Wong CS, Epidural clonidine for postoperative pain after total knee arthroplasty: A dose-response study Anesth Analg 2007 104:1230-35.  [Google Scholar]

[16]Sveticic G, Gentilini A, Eichenberger U, Zanderigo E, Sartori V, Luginbóhl M, Combinations of bupivacaine, fentanyl, and clonidine for lumbar epidural postoperative analgesia: A novel optimization procedure Anesthesiology 2004 101:1381-93.  [Google Scholar]

[17]Mogensen T, Eliasen K, Ejlersen E, Epidural clonidine enhances postoperative analgesia from a combined low-dose epidural bupivacaine and morphine regimen Anesth Analg 1992 75(4):607-10.  [Google Scholar]